TLGT = Market Cap $70 Million / 69 Drugs on Market in USA & Canada / 22 Drugs awaiting FDA approval / Additional 39 Products in Pipeline / Profitability expected this year / Strong Insider & Institutional Ownership (see below) = Cheapest Pharma play out there with significant upside potential ..Fair value is between $6-8 right NOW .GL
Teligent (TLGT)
Market Cap: $70 Million Price: $1.31
Shares Out: 53.7 Million
We currently have 22 Abbreviated New Drug Applications (ANDAs) on file at the FDA, representing a total addressable market of approximately $1.6 billion (IQVIA, June 2018).
Institutional Ownership:
Signet Healthcare Partners LLC 9,851,861 venBio Select Advisor LLC 5,299,431 Elk Creek Partners LLC 4,602,755 BlackRock Fund Advisors 3,257,509 Prosight Management LP 3,240,761 Broadfin Capital LLC 3,052,852 AMI Asset Management Corp. 2,714,292 The Vanguard Group, Inc. 2,165,610 Eversept Partners LP 2,112,098 Sanders Morris Harris LLC (Investment Management) 1,545,032
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.